Sarepta’s Gene Therapy Under Scrutiny After Patient Death
By I. Edwards HealthDay Reporter
WEDNESDAY, March 19, 2025 (HealthDay News) -- A patient has died while receiving Elevidys, a gene therapy for Duchenne muscular...
GLP-1 RA Use Tied to Better Kidney Transplant Outcomes in Patients With Diabetes
Findings show benefits for patient survival
VA Ends Hormone Therapy for Newly Diagnosed Transgender Veterans
By I. Edwards HealthDay Reporter
TUESDAY, March 18, 2025 (HealthDay News) -- The U.S. Department of Veterans Affairs (VA) has announced it will no longer...
AAD: Baricitinib Efficacious for Hair Regrowth in Teens With Severe Alopecia Areata
Significantly more patients receiving baricitinib 2 mg, 4 mg had SALT score ≤20, ≤10 versus placebo at week 36
Metal Mixtures During Pregnancy May Lower Midlife Hypertension Risk
Doubling of vitamin B12 associated with lower systolic and diastolic blood pressure
Roflumilast Cream 0.05 Percent Safe, Effective in Young Children With Eczema
Significant improvement in pruritus seen within 24 hours of first application
COVID-19 Vaccination Not Linked to Major Structural Birth Defects
Vaccination in early pregnancy not linked to prevalence of major structural birth defects in infants
AAD: Maintenance of Low Eczema Activity Seen After About 80 Days Off Tapinarof
Many patients who achieved clear skin with tapinarof treatment maintained low disease activity after treatment-free interval
AAD: Ivarmacitinib 4 mg, 8 mg Efficacious for Adults With Severe Alopecia Areata
No new safety signals or reports of deaths, thromboembolic events, or major cardiovascular events reported
Considerable Proportion of Medical Device Adverse Events Reported Late
9.1 percent were reported after 180 days; small number of manufacturers submitted most of the late reports
